Study details
Enrolling now
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
C5 Biomedical
NCT IDNCT06674980ClinicalTrials.gov data as of Apr 2026
Target enrollment
177
Study length
about 2.1 years
Ages
18+
Locations
1 site in LA
What this study is about
Researchers are testing whether human placental membrane products, used with standard care, are more effective than standard care alone for nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). The trial will last 763 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.AM/Double - DFU
- 2.AM/Double - VLU
- 3.AM/Single - DFU
- +3 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Adverse Events, Change in pain in target ulcer, Determine improvement in quality of life
Body systems
Dermatology, Endocrinology, Cardiology / Heart